期刊文献+

PF方案联合同步放疗治疗Ⅲ期鼻咽癌的临床观察 被引量:3

PF Regimen Combined with Concurrent Radiotherapy for Stage Ⅲ Nasopharyngeal Carcinoma
在线阅读 下载PDF
导出
摘要 目的:观察Ⅲ期鼻咽癌应用PF方案化疗同步放疗的临床效果和毒副反应。方法:将126例Ⅲ期鼻咽癌患者分为放化疗组和单放组。单放组61例,采用^(60)钴常规放疗,DT68Gy~72Gy/7周。放化疗组65例在单纯放疗的基础上联合化疗,PF方案:DDP,30mg,静脉滴注,d_(1~3),5-Fu 500mg,静脉滴注,d_(1~5),亚叶酸钙0.2静脉滴注d_(1~5)。间隔3周后重复,放疗全程中行两次化疗。结果:治疗结束后3个月进行近期疗效评价:放化疗组和单放组患者鼻咽部近期有效率分别为93.8%和93.4%,颈部近期有效率分别为95.4%和93.4%。5年生存率分别为41.5%和26.2%(P<0.05)。放化疗组和单放组的Ⅱ、Ⅲ度呕吐分别为58.5%和26.2%、厌食67.7%和49.2%、脱发73.8%和4.9%,白细胞下降72.3%和63.9%,口腔粘膜炎64.6%和64.4%。结论:两种方法对Ⅲ期鼻咽癌的近期疗效相近,远期疗效放化疗组优于单放组。 Objective: To observe the clinical efficacy and the adverse reaction of PF regimen combined with concurrent radiotherapy for stage Ⅲ nasopharyngeal carcinoma. Methods: 125 cases of nasopharyngeal carcinoma were divided into chemoradiotherapy group and radiotherapy group. The radiotherapy group(61 cases) accepted the routine radiotherapy of ^60Co 68Gy - 72Gy/7 weeks. The chemoradiotherapy group(65 cases) received chemothrapy plus routine radiotherapy. The regimen was: DDP, 30mg intravenously , d1-3,5-Fu, 500mg intravenously, d1-5, LV 0. 2 intravenously, d1-5. Chemotherapy was repeated 3 weeks later and altogether twice were conducted during the process of radiotherapy. Results: The short-term efficacy was assessed 3 months after the treatment which was 93.8% and 93.4% for the nasopharyngeal site of chemoradiotherapy group and radiotherapy group respectively and 95.4% and 93.4% for the neck site of chemoradiotherapy group and radiotherapy group respectively. The 5-year survival rate was 41.5% and 26. 2% (P 〈 0.05) for chemoradiotherapy group and radiotherapy group respectively. The common adverse reaction included Ⅱ and Ⅲ degree vomiting with the incidence of 58.5% and 26.2% , anorexia with the incidence of 67.7% and 49.2%, alopecia with the incidence of 73.8% and 4.9%, leucopenia with the incidence of 72.3% and 63.9%, mucositis with the incidence of 64.6% and 64.4% in chemoradiotherapy group and radiotherapy group respectively. Conclusion: The short-term efficacy of these two kinds of treatment for stage Ⅲ nasopharyngeal carcinoma are close while the long-term efficacy of chemoradiotherapy group is better than that of the radiotherapy group.
出处 《肿瘤预防与治疗》 2010年第6期483-485,共3页 Journal of Cancer Control And Treatment
关键词 鼻咽癌 放射治疗 化学治疗 Nasopharyngeal Carcinoma Radiotherapy Chemotherapy
  • 相关文献

参考文献6

二级参考文献39

  • 1Agarwala SS. Adjuvant chemotherapy in head and neck cancer. Hematol Oncol Clin North Am,1999,13:743-752.
  • 2Borggreven PA,Verdonck-de Leeuw I,Langendijk JA,et al. Speech outcome after surgical treatment for oral and oropharyngeal cancer: a longitudinal assessment of patients reconstructed by a microvascular flap. Head Neck,2005,27:785-793.
  • 3Borggreven PA, Verdonck-de Leeuw I, Rinkel RN, et al. Swallowing after major surgery of the oral cavity or oropharynx : a prospective and longitudinal assessment of patients treated by microvascular soft tissue reconstruction. Head Neck,2007,29:638-647.
  • 4Brizel DM, Esclamado R. Concurrent chemoradiotherapy for locally advanced, nonmetastatic, squamous carcinoma of the head and neck : consensus, controversy, and conundrum. J Clin Oncol,2006, 24:2612- 2617.
  • 5VA laryngeal cancer group study. Induction chemotherapy plus radiation compared with surgery plus radiation in patients with advanced laryngeal cancer. N Engl J Med,1991,324 :1685-1690.
  • 6Forastiere AA,Goepfert H,Maor M,et al. Concurrent chemotherapy and radiotherapy for organ preservation in advanced laryngeal cancer. N Engl J Med,2003,349:2091-2098.
  • 7Urba S, Wolf G, Eisbruch A, et al. Single-cycle induction chemotherapy selects patients with advanced laryngeal cancer for combined chemoradiation: a new treatment paradigm. J Clin Oncol, 2006,24:593-598.
  • 8Fung K, Lyden TH, Lee J, et al. Voice and swallowing outcomes of an organ-preservation trial for advanced laryngeal cancer. Int J Radiat Oncol Biol Phys,2005,63 : 1395-1399.
  • 9Mendenhall WM, Amdur R J, Stringer SP,et al. Radiation therapy for squamous cell carcinoma of the tonsillar region : a preferred alternative to surgery? J Clin Oncol,2000,18:2219-2225.
  • 10Machtay M, Rosenthal DI, Hershock D, et al. Organ preservation therapy using induction plus concurrent chemoradiation for advanced resectable oropharyngeal carcinoma: a University of Pennsylvania Phase II Trial. J Clin Oncol,2002,20:3964-3971.

共引文献627

同被引文献17

引证文献3

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部